Total Payments
$6,525
2024 Payments
$49.59
Companies
33
Transactions
352
Medicare Patients
261
Medicare Billing
$31,280
Payment Breakdown by Category
Food & Beverage$6,472 (99.2%)
Education$52.58 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,472 | 349 | 99.2% |
| Education | $52.58 | 3 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,518 | 60 | $0 (2023) |
| GlaxoSmithKline, LLC. | $1,225 | 90 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $824.51 | 47 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $790.96 | 47 | $0 (2020) |
| Regeneron Healthcare Solutions, Inc. | $297.88 | 15 | $0 (2023) |
| Grifols USA, LLC | $191.52 | 10 | $0 (2023) |
| Actelion Pharmaceuticals US, Inc. | $180.88 | 8 | $0 (2023) |
| Mylan Specialty L.P. | $144.42 | 8 | $0 (2023) |
| Genentech USA, Inc. | $141.63 | 8 | $0 (2019) |
| INSYS Therapeutics Inc | $111.97 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $49.59 | 2 | Boehringer Ingelheim Pharmaceuticals, Inc. ($30.27) |
| 2023 | $546.21 | 27 | GlaxoSmithKline, LLC. ($76.99) |
| 2022 | $978.02 | 45 | AstraZeneca Pharmaceuticals LP ($192.96) |
| 2021 | $832.77 | 44 | GlaxoSmithKline, LLC. ($239.26) |
| 2020 | $708.36 | 37 | AstraZeneca Pharmaceuticals LP ($217.82) |
| 2019 | $1,110 | 75 | GlaxoSmithKline, LLC. ($313.02) |
| 2018 | $938.56 | 59 | AstraZeneca Pharmaceuticals LP ($277.23) |
| 2017 | $1,362 | 63 | AstraZeneca Pharmaceuticals LP ($298.50) |
All Payment Transactions
352 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Cardiology | ||||||
| 03/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.27 | General |
| Category: DIABETES | ||||||
| 12/11/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/31/2023 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Pulmonology | ||||||
| 10/18/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Respiratory | ||||||
| 09/11/2023 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Respiratory | ||||||
| 08/31/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.22 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/19/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/18/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/17/2023 | Inogen, Inc. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $19.69 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 07/05/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: IMMUNOLOGY | ||||||
| 06/16/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: RESPIRATORY | ||||||
| 06/13/2023 | Inogen, Inc. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $16.52 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 06/12/2023 | Bayer Healthcare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Cardio-pulmonary | ||||||
| 06/06/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Immunology | ||||||
| 06/02/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: RESPIRATORY | ||||||
| 05/26/2023 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $14.48 | General |
| Category: Medical Device | ||||||
| 05/05/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/04/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: RESPIRATORY | ||||||
| 03/21/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/08/2023 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: PAH | ||||||
| 03/06/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: Immunology | ||||||
| 02/17/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: RESPIRATORY | ||||||
| 02/07/2023 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug) | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: Cardiology | ||||||
| 02/07/2023 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $15.52 | General |
| Category: Medical Device | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 47 | 71 | $22,213 | $4,674 |
| 2022 | 2 | 44 | 69 | $21,569 | $5,045 |
| 2021 | 4 | 78 | 116 | $39,292 | $10,611 |
| 2020 | 4 | 92 | 131 | $43,929 | $10,950 |
Total Patients
261
Total Services
387
Medicare Billing
$31,280
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 41 | $12,013 | $2,381 | 19.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 18 | 30 | $10,200 | $2,294 | 22.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 29 | 53 | $17,192 | $4,100 | 23.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 16 | $4,377 | $944.75 | 21.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 42 | 77 | $25,102 | $7,027 | 28.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 12 | 12 | $7,476 | $1,933 | 25.9% |
| 99356 | Prolonged inpatient or observation hospital service, first hour | Facility | 2021 | 12 | 12 | $3,384 | $877.56 | 25.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 12 | 15 | $3,330 | $772.63 | 23.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 42 | 78 | $25,428 | $6,214 | 24.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 15 | 15 | $9,345 | $2,462 | 26.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 23 | 26 | $5,772 | $1,377 | 23.9% |
| 99356 | Prolonged inpatient or observation hospital service first hour | Facility | 2020 | 12 | 12 | $3,384 | $897.49 | 26.5% |
About Dr. Kenneth Smith, M.D
Dr. Kenneth Smith, M.D is a Pulmonary Disease healthcare provider based in Metairie, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356310650.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Smith, M.D has received a total of $6,525 in payments from pharmaceutical and medical device companies, with $49.59 received in 2024. These payments were reported across 352 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($6,472).
As a Medicare-enrolled provider, Smith has provided services to 261 Medicare beneficiaries, totaling 387 services with total Medicare billing of $31,280. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Hospice and Palliative Medicine
- Location Metairie, LA
- Active Since 03/17/2006
- Last Updated 02/19/2018
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1356310650
Products in Payments
- TRELEGY ELLIPTA (Drug) $612.23
- BEVESPI AEROSPHERE (Drug) $384.44
- DUPIXENT (Biological) $357.92
- NUCALA (Biological) $304.48
- OFEV (Drug) $303.93
- STIOLTO RESPIMAT (Drug) $301.06
- BROVANA (Drug) $287.33
- SYMBICORT (Drug) $279.66
- FASENRA (Drug) $249.25
- TEZSPIRE (Biological) $218.84
- BREZTRI (Drug) $195.88
- UTIBRON (Drug) $194.96
- LONHALA MAGNAIR (Drug) $166.49
- UPTRAVI (Drug) $163.63
- Prolastin-C Liquid (Biological) $151.50
- ANORO (Drug) $147.59
- Utibron (Drug) $142.18
- BREZTRI AEROSPHERE (Drug) $126.24
- SUBSYS (Drug) $111.97
- Adempas (Drug) $109.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Metairie
Dr. Samuel Seyler, M.d, M.D
Pulmonary Disease — Payments: $11,720
Pulmonary Disease $11,720
Thomas Nuttli, M.d, M.D
Pulmonary Disease — Payments: $9,219
Pulmonary Disease $9,219
Dr. Enrique Diaz Guzman Zavala, M.d, M.D
Pulmonary Disease — Payments: $5,871
Pulmonary Disease $5,871
James Mccullough, M.d, M.D
Pulmonary Disease — Payments: $5,014
Pulmonary Disease $5,014
Henry Jackson, M.d, M.D
Pulmonary Disease — Payments: $948.73
Pulmonary Disease $948.73
Brooks Culotta, Md, MD
Pulmonary Disease — Payments: $808.00
Pulmonary Disease $808.00